NCT07095283

Brief Summary

Stress urinary incontinence (SUI) is defined as the loss of the ability to hold urine after exertion, i.e., as a result of imbalances in intra-abdominal pressure, which directly affect the lower urinary tract. SUI has been shown to have a significant impact on the quality of life of those affected, impacting physical, social, and psycho-emotional aspects. Among the proposed treatments is a physiotherapeutic approach, which is offered as a less invasive and painless therapy with fewer adverse effects than pharmacological or surgical treatment. Pelvic floor muscle training (PFMT) is the most effective physiotherapeutic treatment for SUI, increasing the contractile capacity of the muscles and restoring stability throughout the pelvic diaphragm, thereby ensuring proper support of the pelvic organs. Radiofrequency (RF) therapy is currently being proposed as a therapeutic option that may offer certain advantages over those reported for photoplethysmography (PPMT). The potential benefits of RF therapy are attributed to its ability to stimulate collagen metabolism, thereby promoting tissue regeneration. Radiofrequency (RF) is a non-invasive and painless method that has the potential to yield analogous results to pelvic physical therapy (PPMT) as a standalone treatment or enhance the efficacy of PPMT when administered in conjunction with RF for stress urinary incontinence (SUI). The objective of the present study is to analyse the effectiveness of PFMT and RF as single or combined treatments for SUI in women at Clínica Traña, a clinic specialising in the treatment of pelvic floor dysfunction in Costa Rica. Following the process of obtaining informed consent, patients will be offered a single or combined treatment of RF and/or PFMT. The strength of the pelvic floor muscles, pelvic function and the impact of pelvic dysfunctions on quality of life will be evaluated with a one-year follow-up after the conclusion of treatment. The project possesses the facilities, equipment, and personnel necessary to ensure its viability, as well as proven clinical experience. The scientific and technical impact of the proposed treatment protocol will be achieved by establishing an effective therapeutic strategy to address SUI. The social impact of SUI is significant, given its high prevalence and the fact that it has physical consequences as well as a negative impact on the social activities, work functions and emotions of women who suffer from it.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
239

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 31, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

February 10, 2026

Status Verified

February 1, 2026

Enrollment Period

19 days

First QC Date

July 24, 2025

Last Update Submit

February 9, 2026

Conditions

Keywords

urethral instabilityradiofrequencyphysical exercisefunctional ultrasoundquality of life

Outcome Measures

Primary Outcomes (11)

  • International Consultation on Incontinence Questionnaire (ICIQ-SF)

    0 to 21 points, where higher scores indicate greater impact of incontinence

    Pre - post intervention; after 3,6,12 months

  • King´s Health Questionnaire (KHQ)

    0 to 100, where 0 indicates the best quality of life and 100 the worst

    Pre - post intervention; after 3,6,12 months

  • ultrasound analysis: Resting aperture (Ar)

    degrees

    Pre - post intervention; after 3,6,12 months

  • ultrasound analysis: Opening during exertion (Ae)

    degrees

    Pre - post intervention; after 3,6,12 months

  • Opening difference (Ae-Ar)

    degrees

    Pre - post intervention; after 3,6,12 months

  • MUSCULAR STRENGTH

    defined as the ability of tissue to generate tension based on its contractile capacity, being the best of three attempts to contract, assessed using the modified OXFORD scale

    Pre - post intervention; after 3,6,12 months

  • Function of the pelvic floor muscles

    The best of the three attempts is selected, graded as follows: 0 = no contraction, 1 = partial contraction, 2 = contraction of the pelvic floor muscles + contraction of related muscles, 3 = isolated contraction of the Pelvic floor muscles

    Pre - post intervention; after 3,6,12 months

  • STATIC MUSCLE STRENGTH

    the ability to maintain optimal contraction (isometric, tonic fibers) for as long as possible, measuring the seconds until fatigue sets in. ORDER: "contract and hold," taking the average of the three assessments.

    Pre - post intervention; after 3,6,12 months

  • Fatigability or Dynamic Endurance

    maximum number of contractions in a unit of time, taking 10 seconds as the average. ORDER: "contract as many times as possible and at the highest speed," with the measurement being the average of the three assessments.

    Pre - post intervention; after 3,6,12 months

  • Oxford's Scale

    allows the contractile capacity of the pelvic floor muscles to be assessed. It scores from 0 to 5, as follows: if there is no contraction, it is scored as 0; if the contraction is very weak, it is scored as 1; if the contraction is weak, it is scored as 2; if the contraction is moderate/with tension/and sustained, it is scored as 3; if the contraction is good and maintains tension with resistance, it is scored as 4; and if the contraction is strong and maintains tension against a resistant force, it is scored as 5.

    Pre - post intervention; after 3,6,12 months

  • Sandvik Severity Index

    It allows the severity of UI to be determined based on two questions. Interpretation based on the score is classified as follows: 1-2 mild UI, 3-6 moderate UI, 8-9 severe UI, 12 very severe UI.

    Pre - post intervention; after 3,6,12 months

Secondary Outcomes (11)

  • age (years)

    baseline

  • BMI (Body mass index)

    baseline

  • smoke

    baseline

  • alcohol consumption

    baseline

  • drug use

    baseline

  • +6 more secondary outcomes

Study Arms (3)

RF Therapy

EXPERIMENTAL

Participants will be placed in the lithotomy position. The treatment temperature will be set at 41°C, with a frequency of 1 MHz and power of 75 kJ. Once the indicated temperature has been reached, the physical therapist will perform small upward and downward movements along the urethral canal, dividing the time equally between both sides. One RF session will be performed every 7 days, as described by the author, for a total of 5 sessions. We divided the subjects into mild SUI (1-2 points in the Sandvik test); moderate SUI (Sandvik test of 3 to 6 points), severe SUI (8-9 points Sandvik test); and very severe SUI (12 points in Sandvik test).

Diagnostic Test: Short International Consultation on Incontinence Questionnaire (ICIQ-SF)Diagnostic Test: King's Health Questionnaire (KHQ)Diagnostic Test: Ultrasound evaluationDiagnostic Test: Sandvik Severity IndexDiagnostic Test: Oxford's scaleDiagnostic Test: Biofeedback

Pelvic floor muscle training (PFMT)

EXPERIMENTAL

The PFMT will consist of a targeted program with a protocol of core and pelvic floor exercises established based on an assessment of the patients' strength, endurance, and fatigue, with a frequency of twice a week led by a physical therapist and a duration of 45 minutes each day for a period of 16 weeks. It will be carried out in groups of 8 people and accompanied by a physical therapist experienced in therapeutic exercise. We divided the subjects into mild SUI (1-2 points in the Sandvik test); moderate SUI (Sandvik test of 3 to 6 points), severe SUI (8-9 points Sandvik test); and very severe SUI (12 points in Sandvik test).

Diagnostic Test: Short International Consultation on Incontinence Questionnaire (ICIQ-SF)Diagnostic Test: King's Health Questionnaire (KHQ)Diagnostic Test: Ultrasound evaluationDiagnostic Test: Sandvik Severity IndexDiagnostic Test: Oxford's scaleDiagnostic Test: Biofeedback

combination of RF Therapy and PFMT

EXPERIMENTAL

We divided the subjects into mild SUI (1-2 points in the Sandvik test); moderate SUI (Sandvik test of 3 to 6 points), severe SUI (8-9 points Sandvik test); and very severe SUI (12 points in Sandvik test).

Diagnostic Test: Short International Consultation on Incontinence Questionnaire (ICIQ-SF)Diagnostic Test: King's Health Questionnaire (KHQ)Diagnostic Test: Ultrasound evaluationDiagnostic Test: Sandvik Severity IndexDiagnostic Test: Oxford's scaleDiagnostic Test: Biofeedback

Interventions

Ultrasound evaluationDIAGNOSTIC_TEST

A two-dimensional (2D) ultrasound system with B-mode capability and cine-loop function, a 3.5 to 6 MHz curved convex probe transducer, was used for the perineal image. The examination will be performed in the dorsal lithotomy position, with the hips flexed and slightly abducted and the heels placed close to the buttocks, or in a standing position if necessary.

Pelvic floor muscle training (PFMT)RF Therapycombination of RF Therapy and PFMT
Sandvik Severity IndexDIAGNOSTIC_TEST

It allows the severity of UI to be determined based on two questions. Interpretation based on the score is classified as follows: 1-2 mild UI, 3-6 moderate UI, 8-9 severe UI, 12 very severe UI.

Pelvic floor muscle training (PFMT)RF Therapycombination of RF Therapy and PFMT
Oxford's scaleDIAGNOSTIC_TEST

The strength of the Pelvic floor muscles will be evaluated digitally using functional ultrasound and classified according to the Oxford scale.

Pelvic floor muscle training (PFMT)RF Therapycombination of RF Therapy and PFMT
BiofeedbackDIAGNOSTIC_TEST

Muscular (mmHg) and static strength (seconds); Fatigability or Dynamic Endurance (% and cmH₂O)

Also known as: Muscular and static strength; Fatigability or Dynamic Endurance
Pelvic floor muscle training (PFMT)RF Therapycombination of RF Therapy and PFMT

The KHQ is a self-administered instrument specifically designed to assess quality of life in women with UI. It consists of 21 items distributed across 9 dimensions: perception of overall health (1 item), impact of UI (1 item), limitations in daily activities (2 items), physical limitations (2 items), social limitations (2 items), personal relationships (3 items), emotions (3 items), sleep/energy (2 items), and severity of UI (5 items). The score range for each dimension is from 0 (lowest impact of UI and therefore best quality of life) to 100 (highest impact, worst quality of life). This questionnaire provides an overall value for the quality of life of the patient with UI (Overall Score-OS) and another specific value for each dimension on a scale with the following range: 0: Best possible quality of life - 100: Worst possible quality of life.

Pelvic floor muscle training (PFMT)RF Therapycombination of RF Therapy and PFMT

This is a self-administered questionnaire with four questions and a total score ranging from 0 \[best\] to 21 \[worst\] that identifies people with urinary incontinence and its impact on quality of life.

Pelvic floor muscle training (PFMT)RF Therapycombination of RF Therapy and PFMT

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women over the age of 18 who meet the International Continence Society (ICS)
  • diagnostic criteria for SUI, which consists of involuntary leakage of urine during increased intra-abdominal pressure in the absence of bladder contractions such as coughing, sneezing, and other physical activities.

You may not qualify if:

  • diagnosis of urgent or mixed UI
  • diagnosis of pelvic organ prolapse
  • taking any treatment for UI
  • pregnancy
  • history of pelvic surgery, urinary tract infection, or diagnosed psychological disorders
  • presence of scars, malformations, abnormal pelvic masses, tissue irritation, or any other condition in the area that could be causing pelvic and urinary function problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ceu Cardenal Herrera University

Elche, Alicante, 03204, Spain

Location

MeSH Terms

Conditions

Urinary Incontinence, StressMotor Activity

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

July 24, 2025

First Posted

July 31, 2025

Study Start

August 1, 2025

Primary Completion

August 20, 2025

Study Completion

September 30, 2025

Last Updated

February 10, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

The data associated with this paper will be available in the Zenodo repository

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations